MANTA and MANTA-RAy safety readouts boost Jyseleca’s prospects in the US
Following Galapagos’ announcement of pooled interim results from its ongoing MANTA and MANTA-RAy safety studies for Jyseleca (filgotinib); Rose Joachim, Pharma Analyst at GlobalData, a leading...